Preoperative infliximab therapy does not increase morbidity and mortality after laparoscopic resection for inflammatory bowel disease.
about
Inflammatory bowel disease surgery in the biologic eraAnti-Tumor Necrosis Factor-α Antibody Therapy Management Before and After Intestinal Surgery for Inflammatory Bowel Disease: A CCFA Position PaperA review of the impact of biologics on surgical complications in Crohn's diseaseRisk factors for complications after ileocolonic resection for Crohn's disease with a major focus on the impact of preoperative immunosuppressive and biologic therapy: A retrospective international multicentre study.Effect of preoperative biologic drugs on complications and function after restorative proctocolectomy with primary ileal pouch formation: systematic review and meta-analysis.Systematic review of preoperative, intraoperative and postoperative risk factors for colorectal anastomotic leaks.Association of Preoperative Anti-Tumor Necrosis Factor Therapy With Adverse Postoperative Outcomes in Patients Undergoing Abdominal Surgery for Ulcerative Colitis.The Role of Temporary Fecal Diversion.Short-term outcomes of laparoscopic surgery for Crohn's disease patients treated with anti-tumor necrosis factor alpha agents.Surgical Outcomes in Vedolizumab-Treated Patients with Ulcerative Colitis.Predictive factors for anastomotic leakage after laparoscopic colorectal surgery.NSAID use and anastomotic leaks following elective colorectal surgery: a matched case-control study
P2860
Q26745627-214F0C17-ABB7-48EB-810C-FD4B6AFEA152Q26783978-E2DCDD67-F70E-4D2F-BE2E-CCA049BEDBA7Q26865009-FC6952E6-B264-4285-A8EF-2527D851070FQ37744596-3F08889D-F3E9-43C1-9D27-40E72BD05458Q38291763-BAF2C751-6785-4CF6-87B1-6C4A7E6866EAQ38363780-75CA6FD8-AC37-4312-AB0D-D01CA14C8A15Q38725724-5403655F-F170-4537-8B3D-EE114A8AD77EQ39419599-47BCB5A8-A4B0-42A9-8CC2-78213547295FQ39636883-0726B367-30B4-463E-A5B8-F7FC34F8F99CQ40072921-26542B27-7F4A-4E80-9139-7B1B4CCDAD5DQ55057860-85DC584C-1430-4473-A5B8-88179C2FA517Q57109791-84A433B2-CAB9-4505-BD30-E898FFA5B09F
P2860
Preoperative infliximab therapy does not increase morbidity and mortality after laparoscopic resection for inflammatory bowel disease.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Preoperative infliximab therap ...... or inflammatory bowel disease.
@en
type
label
Preoperative infliximab therap ...... or inflammatory bowel disease.
@en
prefLabel
Preoperative infliximab therap ...... or inflammatory bowel disease.
@en
P2093
P1476
Preoperative infliximab therap ...... or inflammatory bowel disease.
@en
P2093
Alessandro Fichera
Anthony Villa
Konstantin Umanskiy
Marco E Allaix
Marco Zoccali
Michele A Rubin
Mukta K Krane
Roger D Hurst
P304
P356
10.1097/DCR.0B013E3182759029
P577
2013-04-01T00:00:00Z